Projects per year
Personal profile
Biography
Associate Professor Margaret Hibbs
Department of Immunology - Leukocyte Signalling Laboratory
Margaret Hibbs is an Associate Professor in the Department of Immunology, within the Central Clinical School, and Group leader of the Leukocyte Signalling Laboratory.
The Leukocyte Signaling Laboratory is studying signaling pathways that play a role in immune system development and function. We are primarily interested in what regulates the development of immunity and we are trying to understand the processes that are perturbed when autoimmunity and inflammatory diseases develop. We are also interested in understanding what regulates haematopoiesis or blood cell development, and believe that this will give us a greater understanding of the signals that go awry in the development of blood cell cancers. The lab also has a major interest in understanding the mechanisms underlying chronic inflammatory lung disease and we aim to identifying key pathways or targets for therapeutic intervention.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Medicine, PhD, University of Melbourne
Apr 1984 → Feb 1988
Pathology, BSc(Hons), University of Melbourne
1983
Biochemistry and Pathology, BSc, University of Melbourne
1979 → 1982
Research area keywords
- Autoimmunity
- Haematopoiesis
- Chronic inflammatory lung disease
Network
-
Novel therapeutic approaches for SLE
Mackay, F., Mackay, C. & Hibbs, M.
1/12/19 → 1/12/23
Project: Research
-
-
Designing superior killers in cancer immunotherapy
Borger, J., Hibbs, M. & Beavis, P.
1/01/19 → 31/12/19
Project: Research
-
Dissecting the contribution of IL-17-producing γδ T cells to the pathogenesis of airway diseases
Hibbs, M. & Anderson, G. P.
National Health and Medical Research Council (NHMRC) (Australia)
1/01/18 → 31/12/20
Project: Research
-
Advances in Translational Science to Identify New Therapies for Systemic Lupus Erythematosus
Hoi, A., Vincent, F. B. & Hibbs, M. L., 2021, Pathogenesis of Systemic Lupus Erythematosus: Insights from translational research. Hoi, A. (ed.). 1st ed. Cham Switzerland: Springer, p. 1-8 8 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter (Book) › Other › peer-review
-
B Cell-Targeted Therapies in Systemic Lupus Erythematosus
Vincent, F. B., Figgett, W. & Hibbs, M. L., 2021, Pathogenesis of Systemic Lupus Erythematosus: Insights from translational research. Hoi, A. (ed.). 1st ed. Cham Switzerland: Springer, p. 37-52 16 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter (Book) › Other › peer-review
-
Granulocyte colony-stimulating factor is not pathogenic in lupus nephritis
Gottschalk, T. A., Vincent, F. B., Hoi, A. Y. & Hibbs, M. L., Sep 2021, In: Immunity, Inflammation and Disease. 9, 3, p. 758-770 13 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus) -
Hallmark of Systemic Lupus Erythematosus: Role of B Cell Hyperactivity
Vincent, F. B., Figgett, W. & Hibbs, M. L., 2021, Pathogenesis of Systemic Lupus Erythematosus: Insights from translational research. Hoi, A. (ed.). 1st ed. Cham Switzerland: Springer, p. 9-36 28 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter (Book) › Other › peer-review
-
Tetraspanin CD53 modulates lymphocyte trafficking but not systemic autoimmunity in Lyn-deficient mice
Yeung, L., Gottschalk, T. A., Hall, P., Tsantikos, E., Gallagher, R. H., Kitching, A. R., Hibbs, M. L., Wright, M. D. & Hickey, M. J., Nov 2021, In: Immunology and Cell Biology. 99, 10, p. 1053-1066 14 p.Research output: Contribution to journal › Article › Research › peer-review